BHICOTCServices-Computer Processing & Data PreparationFiscal year ends December 31
BioScience Health Innovations, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.78+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $79.22M
- P/E (TTM)
- –
- Dividend yield
- –
BioScience Health Innovations statistics
Financials through Jun 30, 2026, price as of Oct 16, 2026, median of Services-Computer Processing & Data Preparation companies for comparison
Valuation
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| Market Cap | $79.68M | $283.76M |
| Enterprise Value | $78.97M | $296.20M |
| PS Ratio | 17.74 | 2.36 |
| PB Ratio | 43.42 | 2.67 |
| P/TBV Ratio | 46.19 | 4.90 |
Enterprise value
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| EV / Sales | 17.58 | 2.14 |
Income (trailing twelve months)
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| Revenue | $4.49M | $289.17M |
| Gross Profit | $2.42M | $161.98M |
| Operating Income | -$613.24K | -$613.24K |
| Net Income | -$658.07K | -$301.07K |
| EBITDA | -$613.24K | -$156.35K |
| EPS (Diluted) | -$0.06 | $0.00 |
Margins
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| Gross Margin | 53.8% | 55.8% |
| Operating Margin | -13.7% | -1.81% |
| Profit Margin | -14.7% | -1.80% |
| EBITDA Margin | -13.7% | 0.60% |
Returns
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| Return on Equity (ROE) | -37.0% | 0.83% |
| Return on Assets (ROA) | -31.4% | -2.82% |
| Return on Invested Capital (ROIC) | -62.8% | -0.05% |
Growth
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 7.77% | 9.72% |
| Net Income Growth (YoY) | -169.2% | 7.14% |
| EPS Growth (YoY) | -200.0% | 8.91% |
Balance sheet
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $712.38K | $43.42M |
| Net Cash (Debt) | $712.38K | $2.04M |
| Net Cash Per Share | $0.06 | $0.15 |
| Equity (Book Value) | $1.83M | $52.29M |
| Book Value Per Share | $0.16 | $1.93 |
| Tangible Book Value | $1.73M | $3.06M |
Cash flow (trailing twelve months)
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| Operating Cash Flow | -$1.54M | $8.52M |
Efficiency
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| Asset Turnover | 2.14 | 0.64 |
| Inventory Turnover | 3.97 | 13.06 |
Dividends and yields
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| Earnings Yield | -0.83% | -0.92% |
| Buyback Yield | -0.97% | 3.11% |
| Shareholder Yield | -0.97% | 3.32% |
Shares
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| Shares Outstanding | 11,752,300 | 58,826,100 |
| Shares Change (YoY) | -41.6% | 2.21% |
| Shares Change (QoQ) | 7.04% | 0.06% |
| Float | 11,752,300 | 52,938,050 |
| Shares Held by Insiders | 0.00% | 13.2% |
Scores
| Measure | BioScience Health Innovations | Industry median |
|---|---|---|
| Altman Z-Score | 159.80 | 1.50 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from BioScience Health Innovations's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.